StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$945.53−12.23 (-1.28%)

Close on Nov 18, 2026Market cap $97.81BP/E 20.9Yield –

Regeneron Pharmaceuticals Customer Revenue Concentration by Quarter

Customer Revenue Concentration — McKesson Corporation Share of Gross Product Revenue (%) (%)

Regeneron Pharmaceuticals Customer Revenue Concentration: 3,000.0% in Q3 2026, unchanged from a year earlier.

Latest, Q3 2026
3,000.0%
Period ended Sep 30, 2026
Change on a year earlier
0.0 pts
3,000.0% in Q3 2025
History
30 quarters
Since Q1 2017
Sources
27
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q (filed 2026-10-30) ↗

Reported in Form 10-Q / 10-K Note — Concentration of Credit Risk (XBRL).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCustomer Revenue Concentration — McKesson Corporation Share of Gross Product Revenue (%) (%)Year on yearSource
Q3 2026Sep 30, 20263,000.0%0.0 ptsForm 10-Q (filed 2026-10-30) ↗
Q2 2026Jun 30, 20263,200.0%+800.0 ptsForm 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 20263,000.0%+500.0 ptsForm 10-Q (filed 2026-04-29) ↗
Q3 2025Sep 30, 20253,000.0%+600.0 ptsForm 10-Q (filed 2026-10-30) ↗
Q2 2025Jun 30, 20252,400.0%0.0 ptsForm 10-Q (filed 2026-07-30) ↗
Q1 2025Mar 31, 20252,500.0%+100.0 ptsForm 10-Q (filed 2026-04-29) ↗
Q3 2024Sep 30, 20242,400.0%0.0 ptsForm 10-Q (filed 2025-10-28) ↗
Q2 2024Jun 30, 20242,400.0%-100.0 ptsForm 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 20242,400.0%-100.0 ptsForm 10-Q (filed 2025-04-29) ↗
Q3 2023Sep 30, 20232,400.0%-400.0 ptsForm 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 20232,500.0%-300.0 ptsForm 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 20232,500.0%-500.0 ptsForm 10-Q (filed 2024-05-02) ↗
Q3 2022Sep 30, 20222,800.0%+400.0 ptsForm 10-Q (filed 2023-11-02) ↗
Q2 2022Jun 30, 20222,800.0%+1400.0 ptsForm 10-Q (filed 2023-08-03) ↗
Q1 2022Mar 31, 20223,000.0%+100.0 ptsForm 10-Q (filed 2023-05-04) ↗
Q3 2021Sep 30, 20212,400.0%-1000.0 ptsForm 10-Q (filed 2022-11-03) ↗

Cite this data

StockData. (2026). Regeneron Pharmaceuticals Customer Revenue Concentration (%), quarterly Q1 2017–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/conc-mckesson-rev

See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?